Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study

OBJECTIVES: Recent evidence has shown no harm associated with the use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-receptor blockers (ARBs) in patients with coronavirus disease 2019 (COVID-19). We sought to further clarify the possible association between ACEI/ARB use and the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ju Hwan, Baek, Yeon-Hee, Lee, Hyesung, Choe, Young June, Shin, Hyun Joon, Shin, Ju-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Epidemiology 2020
Materias:
COVID-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973148/
https://www.ncbi.nlm.nih.gov/pubmed/33445824
http://dx.doi.org/10.4178/epih.e2021004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973148/
https://www.ncbi.nlm.nih.gov/pubmed/33445824
http://dx.doi.org/10.4178/epih.e2021004

Ejemplares similares